Home › Calculator › BMXXY Dividend Calculator 2026
BMXXY DRIP Calculator & Dividend Yield 2026
1.11% YieldHealthcarebioMérieux S.A. · OTC
Price: $10.19 · Annual div: $0.1128/share · Frequency: annual · Payout ratio: 35% · Ex-div: 2026-06-10
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
BMXXY Dividend Yield
BMXXY (bioMérieux S.A.) has a dividend yield of 1.11%, based on an annual dividend of $0.1128 per share and a price of $10.19. Over the last 12 months it paid $0.1128 per share — a trailing yield of 1.11%. Dividends are paid annual.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When BMXXY pays your bills
Year your monthly dividend income covers each expense (based on current settings)
BMXXY Dividend History — Last 4 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-06-10Latest | 2026-06-26 | $0.1128 | 1.13% | $9.99 |
| 2025-06-10 | 2025-06-26 | $0.1032 | 0.80% | $12.95 |
| 2024-06-10 | 2024-06-26 | $0.0910 | 0.96% | $9.51 |
| 2023-06-06 | 2023-06-23 | $0.0913 | 0.84% | $10.85 |
About bioMérieux S.A. (BMXXY) — Dividend Analysis 2026
bioMérieux S.A. is a global leader in the development and production of in vitro diagnostic solutions, primarily aimed at detecting infectious diseases. Its operations span the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions. The company provides sophisticated diagnostic platforms that analyze biological specimens to pinpoint infectious diseases, cardiovascular conditions, and various cancers. Additionally, it offers microbiological testing for quality control in manufacturing, serving the food, pharmaceutical, cosmetics, and veterinary industries. Its diverse clientele encompasses clinical and hospital laboratories, medical practitioners, blood banks, and industrial control facilities. Founded in 1963, the company, previously known as B-D Mérieux, maintains its headquarters in Marcy l'Etoile, France. bioMérieux S.A. operates as a subsidiary of Institut Mérieux SA.
Similar dividend stocks to BMXXY
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full BMXXY DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BMXXY position with:
🌍 BMXXY Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold BMXXY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1.11% | -1.69% | $111 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.94% | -1.86% | $94 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.89% | -1.91% | $89 / yr |
| 🇬🇧 UK ISA | 0% | 1.11% | -1.69% | $111 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1.01% | -1.79% | $101 / yr |
| 🇨🇦 TFSA | 0% | 1.11% | -1.69% | $111 / yr |
| 🇨🇦 CA Taxable | 25% | 0.83% | -1.97% | $83 / yr |
| 🇦🇺 Super (pension) | 15% | 0.94% | -1.86% | $94 / yr |
| 🇦🇺 AU Taxable | 30% | 0.78% | -2.02% | $78 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.82% | -1.98% | $82 / yr |
| 🇫🇷 FR Taxable | 30% | 0.78% | -2.02% | $78 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 BMXXY Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.11/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 BMXXY Dividend Payment Schedule
BMXXY pays annually — 1 payment per year.
📊 BMXXY vs Healthcare Benchmarks
How BMXXY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BMXXY sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ BMXXY Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare BMXXY with peers: BMXXY vs ALPMY · BMXXY vs GIKLY · BMXXY vs GNMSF
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BMXXY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
bioMérieux S.A. (BMXXY) is currently trading at $10.19, 30% below its 52-week high. The current dividend yield is 1.11% based on an annual payout of $0.1128 per share.
BMXXY (bioMérieux S.A.) — 1.11% Dividend Yield Analysis
bioMérieux S.A. (BMXXY) is a healthcare stock currently trading at $10.19 with a dividend yield of 1.11%. It pays an annual dividend of $0.1128 per share. The payout ratio of 35% suggests the dividend is well-covered by earnings. Over the past 5 years, BMXXY has grown its dividend at a compound annual rate of 35.3%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest BMXXY News
LiveHow investors use the BMXXY dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.